A novel soluble guanylate cyclase activator with reduced risk of hypotension by short‐acting vasodilation
Author:
Affiliation:
1. R&D Department TOA EIYO LTD. Fukushima Research Laboratories Fukushima Japan
2. R&D Department TOA EIYO LTD. Tokyo Research Laboratories Saitama Japan
Publisher
Wiley
Subject
General Pharmacology, Toxicology and Pharmaceutics,Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.463
Reference40 articles.
1. Heart Disease and Stroke Statistics—2016 Update
2. The annual global economic burden of heart failure
3. Why do drugs for acute heart failure fail?
4. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
5. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 685509, a soluble guanylyl cyclase activator, in healthy volunteers: Results from two randomized controlled trials;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-24
2. Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO;Nature Communications;2021-05-11
3. The NO–cGMP–PKG pathway in skeletal remodeling;Annals of the New York Academy of Sciences;2020-08-28
4. Soluble guanylyl cyclase stimulation and phosphodiesterase‐5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats;United European Gastroenterology Journal;2020-01-12
5. Cinaciguat in combination with insulin induces a favorable effect on implant osseointegration in type 2 diabetic rats;Biomedicine & Pharmacotherapy;2019-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3